About us
Leecan Pharmaceutical is a modern, innovative pharmaceutical enterprise integrating independent R&D, manufacturing and sales, focusing on medications for respiratory diseases, psychiatric diseases, immune system diseases, and common chronic diseases. The company is committed to technological breakthroughs and innovation-driven development of high-quality drugs to meet public medication needs and improve patients' quality of life.
The Hefei Headquarters Industry and Research Base in Feixi Economic Development Zone, covering 125 mu (≈83,334 m²) with a construction area of 132,000 m². It specializes in inhalation aerosols, multi-dose powder inhalers, sustained-release solid formulations, liposomes, nanocrystals, and innovative complex formulations. The total investment exceeds 3.5 billion yuan and the annual output value exceeds 2 billion yuan.
The Nanjing R&D and production base is situated in Phase 6 of the Nanjing Jiangbei New Area Pharmaceutical Valley Accelerator. The production facility was operationalized in June 2022, covering high-end inhalation formulations such as inhalation suspensions, inhalation solutions, and inhalation powders, with an annual output value exceeding 1 billion RMB.
